康复新液预防食管曲张静脉套扎术后再出血的疗效观察

目的探析对肝硬化食管曲张静脉套扎术(EVL)患者术后予以康复新液预防再出血的效果。方法抽取我院消化内科收治的82例行肝硬化EVL术患者,按随机数字表法分对照组、研究组,各41例,术后常规预防再出血治疗为对照组,在此基础上联合康复新液治疗为研究组,比较两组预防效果。结果经治疗观察,研究组患者术后早期再出血率较低,且术后胃镜复查其溃疡面愈合有效率较高,与对照组比差异具统计学意义(P<0.05)。结论对肝硬化EVL术后患者予以康复新液治疗,可有效地预防其再出血,并利于溃疡面愈合,促使患者及早康复,值得推广。

Observation on Efficacy of Kangfuxin Solution on Prevention of Rebleeding after Esophageal Variceal Ligation

Objective To explore the effects of Kangfuxin solution on prevention of rebleeding in patients with liver cirrhosis after esophageal variceal ligation(EVL). Methods 82 patients with liver cirrhosis who underwent EVL in the department of gastroenterology of our hospital were collected and divided into control group and study group according to the random number table method, with 41 cases in each group. Patients with routine prevention and treatment of postoperative rebleeding were included in control group, and patients combined with Kangfuxin solution on this basis were included in study group. The preventive effects were compared between the two groups. Results After treatment, the early postoperative rebleeding rate was lower and the effective rate of ulcer surface healing was higher in postoperative gastroscopy review in study group, which were significantly different from those in control group(P<0.05). Conclusion Kangfuxin solution for patients with liver cirrhosis after EVL can effectively prevent rebleeding, and it is beneficial to the ulcer surface healing and promote early recovery of patients. Thus, it is worth promoting.